CD8A and neoplasm: Meanwhile, PD-1 blockade combined with FL-pIC administration resulted in a significant reduction of tumor burden, accompanied by robust infiltration of CD8+ T cells into tumors (Figures 6E–G and Supplementary Figure S4E).